These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity. Neyts J, De Clercq E. Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749 [Abstract] [Full Text] [Related]
9. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. De Clercq E. Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600 [Abstract] [Full Text] [Related]
11. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice. Neyts J, Sobis H, Snoeck R, Vandeputte M, De Clercq E. Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):269-79. PubMed ID: 8390357 [Abstract] [Full Text] [Related]
12. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine. Stals FS, Zeytinoglu A, Havenith M, de Clercq E, Bruggeman CA. Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939 [Abstract] [Full Text] [Related]
16. A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors. Bedard J, May S, Barbeau D, Yuen L, Rando RF, Bowlin TL. Antiviral Res; 1999 Feb; 41(1):35-43. PubMed ID: 10321577 [Abstract] [Full Text] [Related]
17. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Andrei G, Snoeck R, Piette J, Delvenne P, De Clercq E. Oncol Res; 1998 Feb; 10(10):523-31. PubMed ID: 10338155 [Abstract] [Full Text] [Related]
18. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice. Neyts J, Balzarini J, Naesens L, De Clercq E. J Med Virol; 1992 May; 37(1):67-71. PubMed ID: 1320099 [Abstract] [Full Text] [Related]
19. Immunotoxic potential of antiviral drugs: effects of ganciclovir and (S)-1-(3-hydroxy-2-phosphonylmethoxy propyl) cytosine on lymphocyte transformation and delayed-type hypersensitivity responses. Simecka JW, Patel P, Kern ER. Antiviral Res; 1992 May; 18(1):53-64. PubMed ID: 1416903 [Abstract] [Full Text] [Related]
20. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir. Harada K, Eizuru Y, Isashiki Y, Ihara S, Minamishima Y. Arch Virol; 1997 May; 142(2):215-25. PubMed ID: 9125039 [Abstract] [Full Text] [Related] Page: [Next] [New Search]